Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Covalon Technologies (TSE:COV)
:COV
Holding TSE:COV?
Track your performance easily
Earnings Data
Report Date
Mar 04, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.05Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Dec 17, 2018
|% Change Since: -8.36%
|Next Earnings Date:Aug 28, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in the U.S. Medical Consumables business, positive net income, and a strong cash position. However, flat quarter-over-quarter revenue and increased G&A expenses were noted as challenges. Despite these, the company's strategic focus on growth and operational improvements paints a positive outlook.Company Guidance
During Covalon's Q4 2024 earnings call, significant guidance was provided, highlighting the company's robust financial performance and strategic focus. Covalon achieved a 29% year-on-year increase in Q4 revenue, reaching nearly $9 million, while the full fiscal year 2024 revenue grew by 17% to over $31 million. The company reported an adjusted EBITDA of $1.1 million for Q4 and $4.8 million for the year, marking a notable improvement from 2023. Covalon's U.S. Medical Consumables segment drove substantial growth, with a 66% increase for the year, contributing to an overall margin expansion. Operating expenses were reduced by over $2 million, despite the business growing by almost $5 million. The company's cash position nearly doubled to $17 million, with zero debt, setting a strong foundation for accelerated growth initiatives in 2025, including market development, operational optimization, and innovation. The executive team emphasized the importance of continuous improvement and the potential for unlocking significant shareholder value in the coming years.U.S. Medical Consumables Business Growth
The U.S. Medical Consumables business experienced significant growth of more than 65% in 2024, contributing to the company's revenue increase. This growth was achieved with about one-third of the sales team members compared to the previous year.
Positive Net Income and EBITDA
Covalon reported its third consecutive quarter of positive net income and EBITDA, with a full year adjusted EBITDA of almost $5 million, marking a $7.5 million improvement from 2023.
Strong Cash Position
The company increased its cash position to almost $17 million at the end of September 2024, nearly doubling its cash from a year ago, with zero debt.
Revenue Growth and Margin Expansion
Covalon delivered $9 million in Q4 revenue, a 29% growth year-on-year, and $31 million for the full year, a growth of 17%. Margin improvements were driven by operations optimization and cost reductions.
Key Hospital Partnerships
Covalon is a strong partner to 8 of the 10 best U.S. children's hospitals and experienced significant revenue growth in these accounts, with 6 more than doubling revenue in 2024.
---
TSE:COV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:COV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 07, 2025 | C$3.59 | C$3.29 | -8.36% |
| Aug 21, 2024 | C$2.76 | C$3.00 | +8.70% |
| May 29, 2024 | C$1.11 | C$1.72 | +54.95% |
| Feb 28, 2024 | C$1.40 | C$1.31 | -6.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Covalon Technologies (TSE:COV) report earnings?
Covalon Technologies (TSE:COV) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
What is Covalon Technologies (TSE:COV) earnings time?
Covalon Technologies (TSE:COV) earnings time is at Mar 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:COV EPS forecast?
Currently, no data Available
---